The FDA has approved a new attachment for the Renuvion/J-Plasma system to allow limited use for cosmetic surgeries following reports of adverse events and injuries linked to such procedures.
The FDA is warning surgeons not to use the Renuvion/J-Plasma Device for cosmetic skin surgery, due to risks of serious and potentially life-threatening adverse events.
The CDC warns that a California woman remains hospitalized due to long-term methyl mercury exposure from imported skin lightening cream.
A Zostavax lawsuit claims a man suffered nervous system damage due to the side effect of the shingles vaccine.
A new class action lawsuit by an investor group accuses Gilead and other drug makers of antitrust law violations for preventing generic versions of HIV drugs.
Gilead and other drug manufacturers face a class action lawsuit claiming they conspired to keep generic HIV drugs off the market and to artificially inflate HIV drug prices.
A Multihance lawsuit claims the MRI contrast dye gave a Louisiana man a condition known as Gadolinium Deposition Disease.
A new study warns that Truvada, Stribild and similar HIV drugs may be causing neurocognitive degeneration in HIV-positive patients.
A Zostavax lawsuit claims that the vaccine caused shingles complications that resulted in nerve pain long after shingles outbreaks passed.
For years, Medtronic sat on more than 1,000 reports of serious complications linked to its Infuse bone growth products, including life-threatening neck conditions.
